LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Henry Schein Inc

Fermé

SecteurSoins de santé

70.41 0.09

Résumé

Variation du prix de l'action

24h

Actuel

Min

70.15

Max

70.75

Chiffres clés

By Trading Economics

Revenu

17M

113M

Ventes

-23M

3.2B

P/E

Moyenne du Secteur

21.67

51.198

BPA

1.15

Marge bénéficiaire

3.567

Employés

25,000

EBITDA

16M

253M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+4.84% upside

Dividendes

By Dow Jones

Prochains Résultats

5 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1.2B

8.7B

Ouverture précédente

70.32

Clôture précédente

70.41

Sentiment de l'Actualité

By Acuity

44%

56%

151 / 380 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Henry Schein Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

29 janv. 2025, 13:28 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein Sees 4Q EPS Growth as it Confirms KKR Minority-Stake Deal

16 mai 2025, 20:11 UTC

Acquisitions, Fusions, Rachats

Henry Schein: William K. Daniel Joins Board

16 mai 2025, 20:10 UTC

Acquisitions, Fusions, Rachats

Henry Schein: Strategic Investment by KKR Completed

29 janv. 2025, 14:04 UTC

Actualités
Acquisitions, Fusions, Rachats

KKR Builds Stake in Medical-Supply Company -- 2nd Update

29 janv. 2025, 12:54 UTC

Acquisitions, Fusions, Rachats

KKR Builds Stake in Medical-Supply Company -- Update

29 janv. 2025, 12:07 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein Sees 2025 Adjusted Ebitda Up Mid-Single Digits >HSIC

29 janv. 2025, 12:07 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein Sees 2025 Revenue Up Low- to Mid-Single Digits >HSIC

29 janv. 2025, 12:06 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein: KKR Buying $250 Million in New Shares Based on Market Price >HSIC

29 janv. 2025, 12:06 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein Sees 4Q Rev $3.2B >HSIC

29 janv. 2025, 12:03 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein: KKR Representatives Max Lin, William Daniel to Join Board >HSIC

29 janv. 2025, 12:03 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein: KKR Will Have Ability to Boost Stake to 14.9% via Open Market Purchases >HSIC

29 janv. 2025, 12:02 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein Names Robert Hombach an Independent Director >HSIC

29 janv. 2025, 12:02 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein Increases Share-Repurchase Program Authorization by $500 Million >HSIC

29 janv. 2025, 12:02 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein Sees 2025 Adjusted EPS Up Low- to Mid-Single Digits >HSIC

29 janv. 2025, 12:01 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein Sees 4Q Adj EPS $1.19 >HSIC

29 janv. 2025, 12:00 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein, KKR to Collaborate Range of Value Creation Opportunities >HSIC

29 janv. 2025, 12:00 UTC

Résultats
Acquisitions, Fusions, Rachats

Henry Schein: KKR to Become 12% Common Shareholder >HSIC

29 janv. 2025, 10:30 UTC

Actualités
Acquisitions, Fusions, Rachats

KKR Builds Stake in Medical-Supply Company, Reaches Deal for Board Seats -- WSJ

29 janv. 2025, 10:30 UTC

Acquisitions, Fusions, Rachats

Henry Schein Has Already Been an Activist Target -- WSJ

29 janv. 2025, 10:30 UTC

Acquisitions, Fusions, Rachats

Private-Equity Firm KKR to Work to Improve Operations at Medical and Dental Supplier, Sources Say -- WSJ

29 janv. 2025, 10:30 UTC

Acquisitions, Fusions, Rachats

KKR Has Taken a Big Stake in Henry Schein, Will Get Two Board Seats, Sources Say -- WSJ

Comparaison

Variation de prix

Henry Schein Inc prévision

Objectif de Prix

By TipRanks

4.84% hausse

Prévisions sur 12 Mois

Moyen 73.88 USD  4.84%

Haut 86 USD

Bas 55 USD

Basé sur 9 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

9 ratings

3

Achat

5

Maintien

1

Vente

Score Technique

By Trading Central

66.23 / N/ASupport & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Strong Bearish Evidence

Sentiment

By Acuity

151 / 380Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Henry Schein Inc

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.